ZS PHARMA INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | AstraZeneca : potassium drug delayed by manufacturing snag | RE |
| 2015 | AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 25,268,932 | 24,218,537 ( 95.84 %) | 0 | 95.84 % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
- Stock Market
- Equities
- Stock
- Company ZS Pharma Inc
